CompuVax, Inc. announces issuance of Japanese patent covering key RSV antigens
Del Mar, November 9, 2016
CompuVax, Inc. announces the issuance of Japanese patent No. 6023061 covering key antigens for vaccines against the respiratory syncytial virus. These antigens are based on the engineering of epitope scaffolds at Bill Schief's laboratory. The Japanese patent was issued on November 9, 2016 and its duration is until October 5, 2031. The patent was issued to the University of Washington and is exclusively licensed worldwide to CompuVax, Inc.